Adult T-Cell Lymphoma (ATL) With Erythroderma in Indolent Human T-Lymphotropic Virus Type I (HTLV-1) Infection.

adult t-cell lymphoma/leukemia (atl) diagnosis and treatment of htlv-1 infection erythroderma associated with adult t-cell lymphoma mature t-cell malignancy rare lymphoproliferative neoplasm

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2023
Historique:
accepted: 01 07 2023
medline: 2 8 2023
pubmed: 2 8 2023
entrez: 2 8 2023
Statut: epublish

Résumé

Adult T-cell lymphoma (ATL) is a hematological malignancy of CD4+ mature T-lymphocytes commonly associated with chronic human T-lymphotropic virus type I (HTLV-1) infection. Chronic HTLV-1 infection induces oncogenic mutations in CD4+ T-cells, leading to an acute malignant transformation of host cells. Atypically, ATL presents with dermatological and pulmonary symptoms consistent with a "smoldering" disease pattern. We present a case of a 78-year-old male patient with chronic generalized malaise, progressively worsening shortness of breath, and diffuse erythroderma, who was diagnosed with ATL secondary to chronic indolent HTLV-1 infection. We evaluate the multisystemic clinical signs associated with ATL, the comprehensive clinical investigations required to reach a conclusive diagnosis, and the options for long-term clinical management.

Identifiants

pubmed: 37529824
doi: 10.7759/cureus.41264
pmc: PMC10390346
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e41264

Informations de copyright

Copyright © 2023, Qasim et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Clin Pathol. 2007 Dec;60(12):1392-6
pubmed: 18042695
Viruses. 2016 Jun 16;8(6):
pubmed: 27322308
Curr Opin Virol. 2015 Oct;14:93-100
pubmed: 26414684
Nat Rev Cancer. 2007 Apr;7(4):270-80
pubmed: 17384582
Retrovirology. 2009 Aug 03;6:71
pubmed: 19650892
PLoS Pathog. 2014 Apr 03;10(4):e1004040
pubmed: 24699669
Blood. 2015 Dec 10;126(24):2570-7
pubmed: 26361794
Curr Hematol Malig Rep. 2007 Oct;2(4):257-64
pubmed: 20425378
J Oncol Pract. 2017 Aug;13(8):487-492
pubmed: 28796966
Cancer Res. 2005 Jun 1;65(11):4467-70
pubmed: 15930259
J Virol. 2007 Jun;81(12):6731-41
pubmed: 17409138
Int J Cancer. 1987 Dec 15;40(6):741-6
pubmed: 2891624
N Engl J Med. 1983 Aug 4;309(5):257-64
pubmed: 6602943
Semin Diagn Pathol. 2020 Jan;37(1):1-10
pubmed: 31889601
Rev Esp Quimioter. 2019 Dec;32(6):485-496
pubmed: 31648512
Jpn J Cancer Res. 1986 Jan;77(1):21-3
pubmed: 2870044
Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031-5
pubmed: 6979048
Curr Opin Virol. 2016 Oct;20:40-46
pubmed: 27591679

Auteurs

Abeer Qasim (A)

Internal Medicine, BronxCare Health System, Bronx, USA.

Sachin Bhandari (S)

Internal Medicine, BronxCare Health System, Bronx, USA.

Venkata Sri Ramani Peesapati (VSR)

Internal Medicine, BronxCare Health System, Bronx, USA.

Harsh R Parikh (HR)

Internal Medicine, St. George's University School of Medicine, St. George's, GRD.

Aam Baqui (A)

Pathology, BronxCare Health System, Bronx, USA.

Classifications MeSH